Synthesis and Purification of Acamprosate Calcium and its Evaluation by RP-HPLC in Pharmaceutical Dosage forms

Document Type : Research Paper

Authors

1 Department of Chemistry, University of Zanjan, P.O. Box: 45195-313, Zanjan, Iran

2 Department of Chemistry, University of Zanjan, P.O. Box: 45195-313, Zanjan, Iran,

3 Department of Bioscience and Biotechnology, Malek Ashtar University of Technology, Tehran, Iran

10.22034/ijps.2019.101368.1517

Abstract

The purpose of this study is Acamprosate Calcium synthesis of 3-Aminopropane-1-sulfonic acid (Homotaurine) and validation of assay test in the delayed-release tablets by HPLC without organic solvents. The assay method by HPLC was found to be linear in the concentration range of 50 to 200 µg/mL. Successful separation was achieved by isocratic elution on a Phenomenex® C18 column (250 mm × 4.6 mm, 5μm).The mobile phase was triethylammonium phosphate buffer pH: 4.0 (100%) at the flow rate of 1 mL/min using UV detection at 210 nm, column oven temperature 25ºC and injection volume 20 𝜇L. The analytical results were validated by recovery studies. The percentage recovery method was found to be 99.36-100.60%. The LOD and LOQ were found to 0.012 μg/mL and 0.042 μg/mL. All the parameters of validation were in the acceptance range. This developed method was successfully applied for estimate the amount of Acamprosate Calcium in the tablets.

Keywords

References

[1] Espino D, Cruz M. Acamprosate calcium (Campral®): An effective treatment for maintaining abstinence in alcohol-dependent patients in combination with psychosocial support. Pharm. Ther. (2005) 30: 497-505.
[2] Mason B. J, Treatment of alcohol-dependent outpatients with acamprosate: a clinical review. J. Clin. Psychiatry (2001) 62: 42-48.
[3] Saivin S, Hulot T, Chabac S, Potgieter A, Durbin P, Houin G. Clinical pharmacokinetics of acamprosate. Clin. Pharmacokinet (1998) 35 (5): 331-345.
[4] Rhee Y.-S, et al. Investigation of the relationship between in vitro and in vivo release behaviors of acamprosate from enteric-coated tablets. Arch. Pharm. Res. (2008) 31 (6): 798-804.
[5] Aseervadamma M, Babu C. A, Ramanjaneyulu K, Kumar J. S, Basha M. Method Development & Validation of Acamprosate Tablet Dosage Form by RP-HPLC. World J. Pharm. Pharm. Sci. (2014) 3 (12): 984-994.
[6] Babua C, Sreenivasa Rao B, Suresh Reddy K, Naganjaneyulu B. Development and Validation of HPLC Assay Method for the Acamprosate Ca in Commercial Tablets. IJACS. (2013) 2 (1): 46-49.
[7] Bharghavi L, Maheshwari M, Kartheek  N.; Kumar A. A. Rp-Hplc Method Development And Validation For The Quantitative Estimation Of Acamprosate Calcium In Tablets. Int. J. Pharm. Pharm. Sci. (2014) 6 (6): 582-85.
[8] Thangabalan B, Koya A, Chaitanya G, Sunitha N, Babu S. M. Stability Indicating RP–HPLC Method for the Estimation of Acamprosate in Pure and Tablet Dosage Form. AJPA. (2013) 3 (4): 141-146.
[9] Kirankumar A, Mamatha B, Sasikala M, Monika S, Ranganayakulu D. Validated UV spectrophotometric method development and stability studies of acamprosate calcium in bulk and tablet dosage form. Int. J. Pharmtech. Res. (2013) 5 (3): 1241-1246.
[10]         Blanchin M.-D, Baalbaki B, Bosc N, Fabre H. Short-end injection technique in capillary electrophoresis for dissolution testing of tablets. Anal. Chim. Acta (2000) 415 (1-2): 67-73.
[11]         Fabre H, Blanchin M, Bosc N. Capillary electrophoresis for the determination of bromide, chloride and sulfate as impurities in calcium acamprosate. Anal Chim Acta (1999) 381 (1): 29-37.
[12]         Fabre H, Perrin C, Bosc N. Determination of homotaurine as impurity in calcium acamprosate by capillary zone electrophoresis. J. Chromatogr. A (1999) 853 (1-2): 421-430.
[13]         Chabenat C, Ladure P, Blanc-Continsouza D, Boismare F, Boucly P. Determination of calcium acetylhomotaurinate by liquid chromatography with fluorimetric and electrochemical detection. J. Chromatogr. B Biomed. Sci. Appl. (1987) 414: 417-422.
[14]         Ghosh C, Jha V, Shinde C. P, Chakraborty B. S. A LC‐MS analysis of acamprosate from human plasma: pharmacokinetic application. Drug Test Anal. (2011) 3 (10): 735-742.
[15]         Girault J, Gobin P, Fourtillan J. Determination of calcium acetylhomotaurinate in human plasma and urine by combined gas chromatography-negative-ion chemical ionization mass spectrometry. J. Chromatogr. B. Biomed. Sci. Appl. (1990) 530: 295-305.
[16]         Kanala K. M, Chandu B. R, Hwisa N. T, Khagga M, Katakam P, Challa B. Quantification of Acamprosate in human plasma by LC-ESI-MS/MS with solid phase extraction: Application to a bioequivalence study. J. Pharm. Res. (2013) 7 (5): 389-396.
[17]         Rhee, Y.-S, et al. Analysis of acamprosate in beagle dog plasma by LC-MS-MS. Arch. Pharm. Res. (2008) 31 (8): 1035-1039.
Iranian Journal of Pharmaceutical Sciences
Volume 16, Issue 1
January 2020
Pages 19-28

Files

Share

How to cite

Statistics